Winton Capital »

Eledon Pharmaceuticals shares owned by Winton Capital

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $51k 13k 3.94

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Eledon Pharmaceuticals

BVF
BlackRock
Defilade Capital Management
Vanguard Capital Management
Goldman Sachs Group
Ensign Peak Advisors
Geode Capital Management
Catalio Capital Management
Zimmer Partners
Sphera Funds Management
State Street Corporation
AWM Investment Company
UBS Group
Kingdon Capital Management
Millennium Management

View all funds holding Eledon Pharmaceuticals